it was of interest that we found that CDCP1 was phosThe C2 domains (C2 stands for conserved domain 2) phorylated on tyrosine residues in a Src-dependent are eight β strand modules of about 120 amino acids manner, and this prompted us to examine this finding that are found in a large number of eukaryotic proteins in more detail. (Nalefski and Falke, 1996). C2 domains are found in all Here we show that the C2 domain of PKCδ is a phoseukaryotes, including yeast, but are not found in prophotyrosine binding domain. We determine its specifickaryotes. Originally identified in classical/conventional ity by peptide library screens, its affinity by isothermal protein kinases C (PKC), they were found to mediate titration calorimetry, and the structural basis for phoscalcium-dependent lipid binding. However, the resiphotyrosine binding by X-ray diffraction of its crystal dues required for calcium binding in classical PKCs and structure. that PKCδ is tyrosine phosphorylated and that its ki-
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Here we show that the C2 domain of PKCδ is a phoseukaryotes, including yeast, but are not found in prophotyrosine binding domain. We determine its specifickaryotes. Originally identified in classical/conventional ity by peptide library screens, its affinity by isothermal protein kinases C (PKC), they were found to mediate titration calorimetry, and the structural basis for phoscalcium-dependent lipid binding. However, the resiphotyrosine binding by X-ray diffraction of its crystal dues required for calcium binding in classical PKCs and structure. Our data indicate that Src phosphorylates other proteins are not found in all the C2 domains. and binds to CDCP1 by its SH2 domain and the C2 Nonetheless, for several of these proteins the C2 dodomain of PKCδ binds to CDCP1, thus forming a multimain is still known to bind phospholipids (Rizo and protein complex that includes two important kinases. Sudhof, 1998 Figure 1A ). The use of CDCP1 and its ability to interact with the regulatory domain of PKCδ ( Figure 1D ). Src-family kinase inhibitors (PP1, PP2) suggested that p135 tyrosine phosphorylation was controlled by a Src Since the treatment of several cell types with hydrogen peroxide (H 2 O 2 ) initiates signaling events refamily member ( Figure 1B) Figure 1E ). This association of endogenous proteins correlates with the tyrosine phosphorylation of from lysates of cells treated with pervanadate ( Figure  1C ). Using mass spectrometry we identified p135 as CDCP1, as seen in PKCδ immunoprecipitates and in pull-downs using GST-RD ( Figure 1F) . Thus, the tyro-CDCP1, a recently described transmembrane glycosylated protein overexpressed in colon cancer ( The correlation between the tyrosine phosphorylation (residues 1-123) also binds to the phosphopeptide (data not shown). of CDCP1 and an apparently direct association with the regulatory domain of PKCδ suggested that the regulaCompetition experiments showed that the phosphorylated version of the optimal peptide could block the tory domain could contain a phosphotyrosine binding domain. To test this possibility, a completely degenerinteraction of the PKCδ C2 domain with multiple phosphotyrosine proteins, including CDCP1, with an apparated phosphotyrosine peptide library (XXXXpYXXXX, where pY designates the phosphorylated tyrosine) was ent IC 50 of about 500 nM ( Figure 2C ). The affinity of the C2 domain for the optimal peptide was determined screened against the GST-RD PKCδ fusion protein. The results of this screen strongly suggested that the reguusing isothermal titration calorimetry. These experiments showed that the dissociation constant for the latory domain of PKCδ indeed bound specifically to tyrosine-phosphorylated peptides (Table 1) . A subset of optimal phosphopeptide is less than 250 nM (the highest value from three independent determinations) and peptides containing a tyrosine or phenylalanine residue three residues C-terminal to the phosphorylated tyrothe stoichiometry of the interaction is 1 mole phosphopeptide per mole of C2 domain ( Figure 2D ). This affinity sine was preferentially selected. We then screened a second library containing a fixed tyrosine residue at +3 is comparable to affinities reported for binding of optimal phosphopeptides to SH2 and PTB domains (Paw-(XXXXpYXXYX) to obtain more detailed amino acid preferences at other positions. The result of these lison et al., 2001), the only two phosphotyrosine binding domains previously described. brary screens characterized the regulatory domain of PKCδ as containing a phosphotyrosine binding domain To give insight into the structural basis of the phosphotyrosine binding property of the C2 domain, the that has a strong preference for aromatic residues three amino acids C-terminal to the phosphorylated tyrosine, structure of the C2 domain from human PKCδ in complex with the high-affinity phosphotyrosine peptide with the following consensus sequence (Table 1) 
: (Y/F)-(S/A)-(V/I)-pY-(Q/R)-X-(Y/F)-X.
(MALYSIpYQPYVFAKKK) was solved to a 1.7 Å resolution (R cryst = 17.6%, R free = 22.1%; see data collection Since several reports indicated that the PKCδ C2 domain was responsible for protein-protein interactions, and refinement statistics, Table 2 ). The overall C2 structure is very similar to that of the rat PKCδ C2 domain we investigated whether the C2 domain of PKCδ was sufficient for the binding to CDCP1. Notably, the C2 do- 3C and 3D). In addition, the two backbone amides cluster that acts as a continuation of the hydrophobic core in between the two β sheets. This structure exaround the pTyr have direct H bonds to two conserved residues in PKCδ, Asp60 and Glu123, helping to posiplains the peptide library data where the +3 position showed strong preference for aromatic residues, partiction the pTyr into the positive pocket. Notably, a phosphoserine or phosphothreonine side chain would likely ularly tyrosine. Although the peptide library showed some selection for Gln at +1, there is no prominent be too short to reach Arg67 at the bottom of this pocket.
reason for this preference suggested by the structure. The Gln side chain points into the solvent region and The rest of the peptide forms several backbone contacts with the protein either directly or indirectly interacts with Thr58 indirectly through water molecules. Compared to the other two known phosphotyrosine through water molecules, as well as side chain interactions that explain some of the peptide library results binding domains, SH2 and PTB, which primarily recognize residues either C-terminal or N-terminal to pTyr, ( Figure 3D ). There are two direct peptide side chain recognitions by the protein at Ser−2 and Tyr+3. The Ser−2 respectively, the PKCδ C2 domain interacts significantly with both ends of the peptide. side chain forms a hydrogen bond with the Arg6 guanidine head group of the C2 domain, and the Tyr+3 OH Phosphorylation on Tyr64 has been suggested to regulate PKCδ (Joseloff et al., 2002) . Interestingly, this resiinteracts with the backbone amide of Tyr52. In addition, the Tyr+3 aromatic ring stacks onto Met51 and interacts due sits just outside of the positive binding pocket for pTyr. Its OH is 5.46 Å from Arg67, compared to 5.20 Å with Phe+5. Together they form a small hydrophobic and CDCP1 is stabilized mainly through an SH2-pY734 tein the C2 domain is necessary for the interaction between PKCδ and CDCP1, a truncated version of PKCδ was tested for its ability to interact with CDCP1. As in the case of the equivalent OH on pTyr in the bound shown in Figure 5C , the mutant of PKCδ missing the C2 peptide. When phosphorylated, Tyr64 would likely indomain was unable to interact with CDCP1, but Src still teract electrostatically with Arg67, preventing the bindbound to CDCP1. Since His62 in the C2 domain seems ing of phosphopeptides.
to play a major role in the interaction between the C2 Coexpression experiments were used to determine domain and the phosphopeptide, we created a mutant the mechanism of interaction between CDCP1, PKCδ, of PKCδ in which His62 was mutated into an aspartate. and Src. Experiments using HEK293 or U2-OS cells
We also mutated the Arg67 that appears to be crucial showed that PKCδ and Src associated robustly with for phosphate coordination. Mutation of either of these CDCP1 when the two kinases were coexpressed ( nation of the phosphate is achieved mainly through an mains only in the region in which we observed phosphotyrosine binding situated on the opposite side of arginine residue, as in PTB and SH2 domains. Notably, the interaction with the tyrosine is maintained by stackwhere calcium and phospholipids bind in the classical C2 domains. ing against a histidine residue, a mode of binding that has not been observed in phosphotyrosine binding doThis is the first evidence of the presence of a phosphotyrosine binding domain in the structure of a protein mains. Importantly, the affinity of the peptide for the C2 domain is comparable to the affinities reported for SH2 Ser/Thr kinase, thus directly linking tyrosine phosphorylation with serine/threonine phosphorylation. Our findand PTB domains with cognate peptides. Interestingly, the binding site is close to the N and C termini of the ings raise the question of whether other C2 domains are phosphotyrosine binding domains. In terms of the C2 domain; therefore, binding could potentially alter the position of the domain relative to the rest of the protein.
PKC family, the level of homology between all the classical and novel PKCs is around 70% for the C1 domains Because the C2 domain is followed by the pseudosubstrate region, binding of phosphotyrosine to the C2 doand the kinase domains. On the other hand, the homology level for the C2 domain is far less, about 45%, even main could participate in activation of PKCδ as shown for classical PKC when the C2 domain binds to lipids.
between PKCδ and PKC⑀, another member of the novel subfamily. The only close homolog of the C2 domain of (For classical PKCs this event has to be followed by binding of DAG to the C1 domain.) Numerous C2 do-PKCδ is the C2 domain of PKCθ, another nPKC family member, which has a homology of 70%. All the critical mains lack the amino acids residues necessary for calcium binding. However, these calcium-insensitive residues that contact the optimal binding peptide are conserved in PKCθ (Figure 3 
